Abhijit Y.  Talwalkar net worth and biography

Abhijit Talwalkar Biography and Net Worth

https://www.linkedin.com/in/dasdan of iRhythm Technologies

Abhijit Y. Talwalkar has served as a member and Chairman of our board of directors since May 2016. Mr. Talwalkar served as President and Chief Executive Officer of LSI Corporation, a leading provider of silicon, systems, and software technologies for the storage and networking markets, from May 2005 to May 2014. From 1993 to 2005, Mr. Talwalkar was employed by Intel Corporation and held a number of senior management positions, including Corporate Vice President and Co-General Manager of the Digital Enterprise Group, which was comprised of Intel’s business client, server, storage and communications business, and Vice President and General Manager for the Intel Enterprise Platform Group. Prior to joining Intel, Mr. Talwalkar held senior engineering and marketing positions at Sequent Computer Systems, a multiprocessing computer systems design and manufacturer, Bipolar Integrated Technology, Inc., a VLSI bipolar semiconductor company, and Lattice Semiconductor Inc., a service-driven developer of programmable design solutions. Mr. Talwalkar has served on the board of directors for Advanced Micro Devices, a leading provider of highperformance computing, graphics and visualization solutions since August 2017. Since March 2017, Mr. Talwalkar has served as a member of the board of directors of TE Connectivity Ltd. and previously served as an advisor to the board of directors from August 2016 to March 2017. Since 2011, Mr. Talwalkar has served on the board of directors of Lam Research Corporation and has previously served as a member of the board of directors of LSI from May 2005 to May 2014 and the U.S. Semiconductor Industry Association from May 2005 to May 2014. He has served as the Chairman of the Bay Area chapter of the nationwide non-profit organization Friends of the Children since January 2015. He holds a B.S. in Electrical Engineering from Oregon State University.

What is Abhijit Y. Talwalkar's net worth?

The estimated net worth of Abhijit Y. Talwalkar is at least $1.99 million as of November 4th, 2024. Mr. Talwalkar owns 18,941 shares of iRhythm Technologies stock worth more than $1,988,047 as of March 26th. This net worth estimate does not reflect any other assets that Mr. Talwalkar may own. Learn More about Abhijit Y. Talwalkar's net worth.

How do I contact Abhijit Y. Talwalkar?

The corporate mailing address for Mr. Talwalkar and other iRhythm Technologies executives is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. iRhythm Technologies can also be reached via phone at (415) 632-5700 and via email at investors@irhythmtech.com. Learn More on Abhijit Y. Talwalkar's contact information.

Has Abhijit Y. Talwalkar been buying or selling shares of iRhythm Technologies?

Abhijit Y. Talwalkar has not been actively trading shares of iRhythm Technologies during the last quarter. Most recently, on Monday, November 4th, Abhijit Y. Talwalkar bought 6,664 shares of iRhythm Technologies stock. The stock was acquired at an average cost of $75.16 per share, with a total value of $500,866.24. Following the completion of the transaction, the director now directly owns 18,941 shares of the company's stock, valued at $1,423,605.56. Learn More on Abhijit Y. Talwalkar's trading history.

Who are iRhythm Technologies' active insiders?

iRhythm Technologies' insider roster includes C. Bairey Merz (Director), Quentin Blackford (CEO), Mark Day (EVP), Douglas Devine (CFO), Patrick Murphy (EVP), Chad Patterson (Chief Commercial Officer), Sumi Shrishrimal (EVP, Chief Risk Officer), Mervin Smith (EVP of Business Operations), Abhijit Talwalkar (https://www.linkedin.com/in/dasdan), Minang Turakhia (Chief Medical Officer, Chief Scientific Officer and EVP, Product Innovation), David Vort (EVP), and Daniel Wilson (EVP). Learn More on iRhythm Technologies' active insiders.

Are insiders buying or selling shares of iRhythm Technologies?

In the last year, iRhythm Technologies insiders bought shares 2 times. They purchased a total of 6,944 shares worth more than $521,860.64. In the last year, insiders at the sold shares 8 times. They sold a total of 26,754 shares worth more than $2,130,804.72. The most recent insider tranaction occured on December, 2nd when insider Patrick Michael Murphy sold 2,492 shares worth more than $214,037.88. Insiders at iRhythm Technologies own 0.7% of the company. Learn More about insider trades at iRhythm Technologies.

Information on this page was last updated on 12/2/2024.

Abhijit Y. Talwalkar Insider Trading History at iRhythm Technologies

See Full Table

Abhijit Y. Talwalkar Buying and Selling Activity at iRhythm Technologies

This chart shows Abhijit Y Talwalkar's buying and selling at iRhythm Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

iRhythm Technologies Company Overview

iRhythm Technologies logo
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $104.96
Low: $103.58
High: $106.88

50 Day Range

MA: $108.14
Low: $97.77
High: $119.58

2 Week Range

Now: $104.96
Low: $55.92
High: $128.52

Volume

202,693 shs

Average Volume

457,891 shs

Market Capitalization

$3.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36